369 related articles for article (PubMed ID: 22958493)
21. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.
Wolf G; Chen S; Ziyadeh FN
Diabetes; 2005 Jun; 54(6):1626-34. PubMed ID: 15919782
[TBL] [Abstract][Full Text] [Related]
22. Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products.
McRobert EA; Bach LA
Nephrology (Carlton); 2016 Jan; 21(1):13-20. PubMed ID: 26032400
[TBL] [Abstract][Full Text] [Related]
23. Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice.
Veron D; Aggarwal PK; Velazquez H; Kashgarian M; Moeckel G; Tufro A
J Am Soc Nephrol; 2014 Aug; 25(8):1814-24. PubMed ID: 24578128
[TBL] [Abstract][Full Text] [Related]
24. Renin-angiotensin system within the diabetic podocyte.
Márquez E; Riera M; Pascual J; Soler MJ
Am J Physiol Renal Physiol; 2015 Jan; 308(1):F1-10. PubMed ID: 25339703
[TBL] [Abstract][Full Text] [Related]
25. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
[TBL] [Abstract][Full Text] [Related]
26. Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy.
Oltean S; Qiu Y; Ferguson JK; Stevens M; Neal C; Russell A; Kaura A; Arkill KP; Harris K; Symonds C; Lacey K; Wijeyaratne L; Gammons M; Wylie E; Hulse RP; Alsop C; Cope G; Damodaran G; Betteridge KB; Ramnath R; Satchell SC; Foster RR; Ballmer-Hofer K; Donaldson LF; Barratt J; Baelde HJ; Harper SJ; Bates DO; Salmon AH
J Am Soc Nephrol; 2015 Aug; 26(8):1889-904. PubMed ID: 25542969
[TBL] [Abstract][Full Text] [Related]
27. Podocytes, signaling pathways, and vascular factors in diabetic kidney disease.
Brosius FC; Coward RJ
Adv Chronic Kidney Dis; 2014 May; 21(3):304-10. PubMed ID: 24780459
[TBL] [Abstract][Full Text] [Related]
28. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T
Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445
[TBL] [Abstract][Full Text] [Related]
29. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
30. Role of AGEs in diabetic nephropathy.
Fukami K; Yamagishi S; Ueda S; Okuda S
Curr Pharm Des; 2008; 14(10):946-52. PubMed ID: 18473844
[TBL] [Abstract][Full Text] [Related]
31. Podocyte hypertrophy in diabetic nephropathy.
Kim NH
Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
[TBL] [Abstract][Full Text] [Related]
32. Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.
Jourdan T; Szanda G; Rosenberg AZ; Tam J; Earley BJ; Godlewski G; Cinar R; Liu Z; Liu J; Ju C; Pacher P; Kunos G
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5420-8. PubMed ID: 25422468
[TBL] [Abstract][Full Text] [Related]
33. The podocyte in diabetic kidney disease.
Stitt-Cavanagh E; MacLeod L; Kennedy C
ScientificWorldJournal; 2009 Oct; 9():1127-39. PubMed ID: 19838599
[TBL] [Abstract][Full Text] [Related]
34. Glomerular cell death and inflammation with high-protein diet and diabetes.
Meek RL; LeBoeuf RC; Saha SA; Alpers CE; Hudkins KL; Cooney SK; Anderberg RJ; Tuttle KR
Nephrol Dial Transplant; 2013 Jul; 28(7):1711-20. PubMed ID: 23314315
[TBL] [Abstract][Full Text] [Related]
35. Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy.
Lin CL; Wang FS; Hsu YC; Chen CN; Tseng MJ; Saleem MA; Chang PJ; Wang JY
Diabetes; 2010 Aug; 59(8):1915-25. PubMed ID: 20522599
[TBL] [Abstract][Full Text] [Related]
36. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
37. Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy.
Zhang L; Wen Z; Han L; Zheng Y; Wei Y; Wang X; Wang Q; Fang X; Zhao L; Tong X
J Diabetes Res; 2020; 2020():7504798. PubMed ID: 32695831
[TBL] [Abstract][Full Text] [Related]
38. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.
Veron D; Villegas G; Aggarwal PK; Bertuccio C; Jimenez J; Velazquez H; Reidy K; Abrahamson DR; Moeckel G; Kashgarian M; Tufro A
PLoS One; 2012; 7(7):e40589. PubMed ID: 22808199
[TBL] [Abstract][Full Text] [Related]
39. Reversibility of structural and functional damage in a model of advanced diabetic nephropathy.
Pichaiwong W; Hudkins KL; Wietecha T; Nguyen TQ; Tachaudomdach C; Li W; Askari B; Kobayashi T; O'Brien KD; Pippin JW; Shankland SJ; Alpers CE
J Am Soc Nephrol; 2013 Jun; 24(7):1088-102. PubMed ID: 23641056
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.
Eremina V; Cui S; Gerber H; Ferrara N; Haigh J; Nagy A; Ema M; Rossant J; Jothy S; Miner JH; Quaggin SE
J Am Soc Nephrol; 2006 Mar; 17(3):724-35. PubMed ID: 16436493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
